TMOD-36. SUCCESSFUL GENERATION OF FIVE PATIENT-DERIVED ENDOGENOUS IDH1 MUTANT GLIOMA CELL LINES PROVIDES OPPORTUNITIES FOR DEVELOPMENT OF NEW TREATMENT STRATEGIES FOR IDH MUTANT GLIOMAS | Zendy

AI Assistant Blog Pricing

TMOD-36. SUCCESSFUL GENERATION OF FIVE PATIENT-DERIVED ENDOGENOUS IDH1 MUTANT GLIOMA CELL LINES PROVIDES OPPORTUNITIES FOR DEVELOPMENT OF NEW TREATMENT STRATEGIES FOR IDH MUTANT GLIOMAS

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.